Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2009 | Hbsag Clearance Continues to Increase Post-Treatment in Patients with Hcv Hbv Coinfection Treated with Peginterferon Alfa-2a Plus Ribavirin: 1.5 Year Follow-Up | LIU, CHUN-JEN; WU, SHUN-SHENG; CHAO, YOU- CHEN; YANG, SIEN-SING; LIN, CHIH-LIN; KAO, JIA-HORNG; LIU, CHEN-HUA; CHEN, PEI-JER; CHEN, DING-SHINN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN | HEPATOLOGY | | | |
2009 | Hbv Genotypes and Chronicification of Acute Hepatitis B: More Questions Than Answers | LIN, CHIH-LIN; KAO, JIA-HORNG | GUT | | | |
2022 | Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study | CHEN-HUA LIU ; HSIN-YUN SUN ; Peng, Cheng-Yuan; SZU-MIN HSIEH ; Yang, Sheng-Shun; Kao, Wei-Yu; Shih, Yu-Lueng; Lin, Chih-Lin; Liu, Chun-Jen; Sheng, Wang-Hui; Lo, Yi-Chun; Liu, Wen-Chun; Wu, Jo-Hsuan; TUNG-HUNG SU ; Tseng, Tai-Chung; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Open forum infectious diseases | 3 | 0 | |
2022 | Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B | Hsueh, Rei-Chi; Wu, Wan-Jung; Lin, Chih-Lin; CHUN-JEN LIU ; Huang, Yi-Wen; Hu, Jui-Ting; Wu, Chih-Feng; Sung, Feng-Yu; Liu, Wen-Jie; MING-WHEI YU | Journal of Hepatocellular Carcinoma | | 5 | |
2012 | Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin | CHEN-HUA LIU ; Liang, Cheng-Chao; CHUN-JEN LIU ; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; TUNG-HUNG SU ; JOU-WEI LIN ; Chen, Jun-Herng; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral therapy | 21 | 22 | |
2021 | Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | YU-YUN SHAO ; Wang, Shen-Yung; Lin, Shi-Ming; Chen, Kuan-Yang; Tseng, Jeng-Hwei; MING-CHIH HO ; Lee, Rheun-Chuan; PO-CHIN LIANG ; Liao, Li-Ying; KAI-WEN HUANG ; Hu, Jui-Ting; JA-DER LIANG ; Kee, Kwong-Ming; Lin, Chih-Lin; Wang, Chung-Kwe; Lu, Sheng-Nan; Wang, Jing-Houng; Lee, Wei-Chen; CHIEN-HUNG CHEN ; CHUN-JEN LIU ; Huang, Yi-Hsiang; Wang, Chia-Chi; Wang, Tsang-En; Chuang, Po-Heng; Dai, Chia-Yen; CHIUN HSU ; Chen, San-Chi; Hsieh, Chia-Hsun | Journal of the Formosan Medical Association | 43 | 50 | |
2022 | Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B | MING-WHEI YU ; Lin, Chih-Lin; CHUN-JEN LIU ; Wu, Wan-Jung; Hu, Jui-Ting; Huang, Yi-Wen | Cancers | 1 | 1 | |
2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
2012 | Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses | Liu, Chun-Jen; Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Wu, Shun-Sheng; Yang, Sien-Sing; Kao, Jia-Horng; Lin, Chih-Lin; Chen, Pei-Jer; Chen, Ding-Shinn | Hepatology | | | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2013 | Risk stratification for hepatitis B virus related hepatocellular carcinoma | Lin, Chih-Lin; Lin, Chih-Lin; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | |  |